Literature DB >> 24393849

Genetic variants affecting alternative splicing of human cholesteryl ester transfer protein.

Adam Suhy1, Katherine Hartmann2, Leslie Newman2, Audrey Papp2, Thomas Toneff3, Vivian Hook3, Wolfgang Sadee2.   

Abstract

Cholesteryl ester transfer protein (CETP) plays an important role in reverse cholesterol transport, with decreased CETP activity increasing HDL levels. Formation of an alternative splice form lacking exon 9 (Δ9-CETP) has been associated with two single nucleotide polymorphisms (SNPs) in high linkage disequilibrium with each other, namely rs9930761 T>C located in intron 8 in a putative splicing branch site and rs5883 C>T in a possible exonic splicing enhancer (ESE) site in exon 9. To assess the relative effect of rs9930761 and rs5883 on splicing, mini-gene constructs spanning CETP exons 8 to 10, carrying all four possible allele combinations, were transfected into HEK293 and HepG2 cells. The minor T allele of rs5883 enhanced splicing significantly in both cell lines whereas the minor C allele of rs9930761 did not. In combination, the two alleles did not yield greater splicing than the rs5883 T allele alone in HepG2 cells. These results indicate that the genetic effect on CETP splicing is largely attributable to rs5883. We also confirm that Δ9-CETP protein is expressed in the liver but fails to circulate in the blood.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alternative splicing; CETP levels in liver and plasma; Cholesteryl ester transfer protein; Coronary artery disease; Statin

Mesh:

Substances:

Year:  2014        PMID: 24393849      PMCID: PMC3929938          DOI: 10.1016/j.bbrc.2013.12.127

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.

Authors:  L M Mende-Mueller; T Toneff; S R Hwang; M F Chesselet; V Y Hook
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

2.  Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.

Authors:  Thomas Toneff; Lydiane Funkelstein; Charles Mosier; Armen Abagyan; Michael Ziegler; Vivian Hook
Journal:  Peptides       Date:  2013-06-06       Impact factor: 3.750

3.  Extensive association analysis between the CETP gene and coronary heart disease phenotypes reveals several putative functional polymorphisms and gene-environment interaction.

Authors:  M Corbex; O Poirier; F Fumeron; D Betoulle; A Evans; J B Ruidavets; D Arveiler; G Luc; L Tiret; F Cambien
Journal:  Genet Epidemiol       Date:  2000-07       Impact factor: 2.135

Review 4.  Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.

Authors:  Makoto Nagano; Shizuya Yamashita; Ken-Ichi Hirano; Mayumi Takano; Takao Maruyama; Mitsuaki Ishihara; Yukiko Sagehashi; Takeshi Kujiraoka; Kazuya Tanaka; Hiroaki Hattori; Naohiko Sakai; Norimichi Nakajima; Tohru Egashira; Yuji Matsuzawa
Journal:  J Atheroscler Thromb       Date:  2004       Impact factor: 4.928

5.  Alternative splicing of the mRNA encoding the human cholesteryl ester transfer protein.

Authors:  A Inazu; E M Quinet; S Wang; M L Brown; S Stevenson; M L Barr; P Moulin; A R Tall
Journal:  Biochemistry       Date:  1992-03-03       Impact factor: 3.162

6.  A gene atlas of the mouse and human protein-encoding transcriptomes.

Authors:  Andrew I Su; Tim Wiltshire; Serge Batalov; Hilmar Lapp; Keith A Ching; David Block; Jie Zhang; Richard Soden; Mimi Hayakawa; Gabriel Kreiman; Michael P Cooke; John R Walker; John B Hogenesch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-09       Impact factor: 11.205

7.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

8.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Authors:  D J Gordon; J L Probstfield; R J Garrison; J D Neaton; W P Castelli; J D Knoke; D R Jacobs; S Bangdiwala; H A Tyroler
Journal:  Circulation       Date:  1989-01       Impact factor: 29.690

9.  Health inequalities among British civil servants: the Whitehall II study.

Authors:  M G Marmot; G D Smith; S Stansfeld; C Patel; F North; J Head; I White; E Brunner; A Feeney
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

10.  Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA splicing, HDL levels, and sex-dependent cardiovascular risk.

Authors:  Audrey C Papp; Julia K Pinsonneault; Danxin Wang; Leslie C Newman; Yan Gong; Julie A Johnson; Carl J Pepine; Meena Kumari; Aroon D Hingorani; Philippa J Talmud; Sonia Shah; Steve E Humphries; Wolfgang Sadee
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more
  4 in total

1.  Regulation of cholesteryl ester transfer protein expression by upstream polymorphisms: reduced expression associated with rs247616.

Authors:  Adam Suhy; Katherine Hartmann; Audrey C Papp; Danxin Wang; Wolfgang Sadee
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

2.  Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A.

Authors:  Weiguo Chen; Yang Liu; Hongxing Li; Shuang Chang; Dingming Shu; Huanmin Zhang; Feng Chen; Qingmei Xie
Journal:  Sci Rep       Date:  2015-04-15       Impact factor: 4.379

3.  Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array.

Authors:  Stephanie A Bien; Genevieve L Wojcik; Niha Zubair; Christopher R Gignoux; Alicia R Martin; Jonathan M Kocarnik; Lisa W Martin; Steven Buyske; Jeffrey Haessler; Ryan W Walker; Iona Cheng; Mariaelisa Graff; Lucy Xia; Nora Franceschini; Tara Matise; Regina James; Lucia Hindorff; Loic Le Marchand; Kari E North; Christopher A Haiman; Ulrike Peters; Ruth J F Loos; Charles L Kooperberg; Carlos D Bustamante; Eimear E Kenny; Christopher S Carlson
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

4.  A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276.

Authors:  Xiaobo Yu; Bajin Wei; Rong Su; Jia Yao; Xiaowen Feng; Guoping Jiang; Haiyang Xie; Jian Wu; Xiao Xu; Min Zhang; Shusen Zheng; Lin Zhou
Journal:  Mol Genet Genomic Med       Date:  2019-05-01       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.